Spectrum of Tamoxifen Associated Endometrial Pathology in breast cancer patients

Journal of the Pakistan Medical Association

Volumn 59, Issue 4, 2009, Pages 249-250

  Qureshi, Asim ^a   Bukhari, Farhan ^a   Pervez, Shahid ^a  

^a AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; TAMOXIFEN;

ADULT; ARTICLE; BLEEDING; BREAST CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; CURETTAGE; ENDOMETRIUM BIOPSY; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; ENDOMETRIUM POLYP; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LONG TERM CARE; TREATMENT DURATION;

ADULT; BREAST NEOPLASMS; CASE-CONTROL STUDIES; COMORBIDITY; DILATATION AND CURETTAGE; ENDOMETRIUM; ESTROGEN ANTAGONISTS; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; TAMOXIFEN; UTERINE DISEASES;

EID: 65749083087     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Grady G, Ernster VL. Endometrial cancer. In; Scottenfeld D Fraumen jjR editors. Cancer epidemiology and prevention. 2nd Ed. New York: Saunders, 1996; pp 1058-1089
2. Liao S, Witte D, Schilling K, Chang C. The use of a hydroxylapatite filler steroid receptor assay method in the study of the modulation of androgen receptor interaction. J Steroid Biochem 1984; 20:11-17 (Pubitemid 14127397)
3. Fisher B, Costatino J, Redmond C, Poisson R, Bowman D, Couture J, et al. A randomized clinical trial evaluating tamoxifen on the treatment of patients with node negative breast cancer who have estrogen receptor positive tumors. N Engl J Med 1989; 320:479-484
4. Fornander T, Rutqvist LE, Cedermak B, Glas U, Mattsson A, Silfversward C, Skoog L, et al. Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers. Lancet 1989; 1:117-120
5. Gal D,Kopel S, Bashevkin M, Lebowicz J, Lev R, Taneer ML. Oncogenic potential of tamoxifen on endometria of postmenopausal women with breast cancer: a preliminary report. Gynecol oncol 1991; 42:120-123
6. Van Leeuwen FE, Benraadt J, Coebergh JW, Kiemeney LA, Gimbrere CH, Otter R, et al. Risk of endometrial cancer after tamoxifen treatment of breast cancer. Lancet 1994; 343:448-452
7. Corley D,Rowe J, Curtis MT, Hogan WM, Noumoff JS, Livolsi VA. Post menopausal bleeding from unusual endometrial polyps in women on chronic tamoxifen therapy. Obstet Gynecol 1992; 79:111-116
8. Deligdisch L, Kalir T, Cohen CJ, de Latour M, Le Bovedec G, Penault-Llorca F. Endometrial histopathology in 700 patients treated with tamoxifen for breast cancer. Gynecol Oncol 2000 ; 78:181-186 (Pubitemid 30650351)
9. Office for national cancer statistics. Reistration for cancer diagnosed in 1998 series MBI no 29 London UK Office for National Statistics, 2002.
10. Dallenbach-Hellweg G, Schmidt D Hellberg P, Bourne T, Kreuzwieser E, Doren M, Rydh W, et al. The endometrium in breast cancer patients on tamoxifen. Arch Gynecol Obstet 2000; 263:170-177